Followers | 697 |
Posts | 34940 |
Boards Moderated | 3 |
Alias Born | 05/30/2011 |
Sunday, April 09, 2023 12:41:24 AM
Recent QNCX News
- Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference • Business Wire • 05/06/2024 08:05:00 PM
- Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results • Business Wire • 04/01/2024 11:00:00 AM
- Quince Therapeutics Launches Scientific Advisory Board • Business Wire • 02/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:00:43 PM
- Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors • Business Wire • 02/15/2024 12:00:00 PM
- Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference • Business Wire • 02/07/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 10:53:07 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/05/2024 09:01:33 PM
- Quince Therapeutics to Participate at Investor Events in January 2024 • Business Wire • 01/04/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:02:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:08:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 11:21:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:06:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 11:30:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 06:38:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 09:54:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2023 11:42:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2023 11:34:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:05:58 PM
- Quince Therapeutics Completes Acquisition of EryDel S.p.A. • Business Wire • 10/23/2023 11:00:00 AM
- Quince Therapeutics to Advance Study of EryDex as FDA Lifts Application Hold • Dow Jones News • 09/28/2023 08:53:00 PM
- U.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia • Business Wire • 09/28/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 11:18:03 AM
- Quince Therapeutics Appoints Dr. Charles S. Ryan as President • Business Wire • 09/06/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/31/2023 10:42:15 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM